What Prescription Is Too High for LASIK?

Laser-Assisted In Situ Keratomileusis, or LASIK, is a widely performed refractive procedure designed to correct common vision errors by reshaping the cornea. This surgery uses a highly precise excimer laser to adjust the eye’s focusing power, reducing or eliminating the need for glasses or contact lenses. While millions have successfully undergone the procedure, it is not a universally applicable solution for everyone seeking visual freedom. A comprehensive pre-operative evaluation is required to determine candidacy, with the strength of a patient’s prescription being one of the most significant factors in that decision. The limits of a safe correction are defined by a complex interplay of the prescription itself and the physical anatomy of the eye.

Defining the Maximum Prescription Limits

The question of what prescription is too high for LASIK is answered by numerical thresholds measured in diopters (D). These limits represent conservative guidelines established to maintain patient safety and achieve predictable outcomes. For myopia (nearsightedness), the upper limit for safe LASIK correction typically falls in the range of -10.00 D to -12.00 D. Many surgeons prefer to stay below -12.00 D, even if advanced laser platforms are approved for higher corrections.

Hyperopia (farsightedness) presents a different challenge, and the treatable range is generally lower due to the nature of the corneal reshaping required. Most surgeons set the maximum correction limit for hyperopia between +4.00 D and +6.00 D. Astigmatism, caused by an irregularly shaped cornea, can often be corrected alongside myopia or hyperopia, with a typical upper threshold of 5.00 D to 6.00 D. Exceeding these parameters significantly increases the risk of complications and reduces the probability of a successful result.

The Role of Corneal Thickness and Safety

The reason prescription limits exist is directly linked to the cornea’s physical structure. LASIK works by ablating, or removing, a microscopic amount of tissue from the central corneal stroma, and the amount removed is proportional to the refractive error. Therefore, patients with high prescriptions must have corneas that are sufficiently thick.

During the procedure, a thin flap is created on the cornea’s surface, and the excimer laser reshapes the underlying tissue. A primary safety concern is the thickness of the remaining tissue underneath the flap, known as the Residual Stromal Bed (RSB). To prevent post-LASIK ectasia (a progressive corneal weakening condition), the RSB must be at least 250 micrometers (µm) thick after surgery.

Many surgeons prefer to leave an even greater safety margin, often aiming for an RSB of 270 µm to 300 µm. If a patient’s initial corneal thickness combined with their high prescription would result in an RSB below this threshold, they are disqualified from LASIK. This structural limitation is the fundamental reason a prescription is deemed too high, prioritizing the long-term stability of the eye.

Other Critical Eligibility Criteria Beyond Prescription

While prescription strength and corneal thickness are paramount, several other factors determine if a patient is a suitable candidate for LASIK. The stability of the refractive error is a prerequisite for any permanent vision correction procedure. Candidates must demonstrate that their prescription has remained stable (no change greater than 0.5 D) for at least one to two years. Undergoing surgery while the eye is still changing would lead to the prescription returning shortly after the procedure.

A thorough assessment of ocular health is non-negotiable before surgery. Pre-existing conditions such as severe dry eye syndrome, uncontrolled glaucoma, advanced cataracts, or degenerative corneal diseases like keratoconus will preclude a patient from LASIK. The size of a patient’s pupils in dim light is also evaluated, as large pupils can increase the likelihood of nighttime visual disturbances like glare or halos post-surgery.

General systemic health also plays a role in the healing process. Conditions that impair the body’s ability to heal or increase the risk of infection, such as uncontrolled diabetes or certain autoimmune disorders, may make LASIK unsafe. These non-refractive factors are assessed during the pre-operative consultation and can independently disqualify a candidate.

Surgical Alternatives for High Refractive Errors

For individuals whose prescription is too high for LASIK or who have corneas that are too thin, alternative surgical options can still provide excellent vision correction. Photorefractive Keratectomy (PRK) is a surface ablation technique often recommended for patients with moderate prescriptions and thin corneas. Since PRK does not involve creating a corneal flap, it preserves more structural integrity, making it a viable option when the Residual Stromal Bed (RSB) threshold is a concern.

For very high degrees of myopia, particularly those exceeding -10.00 D, Implantable Collamer Lenses (ICL), or phakic intraocular lenses, are frequently the preferred method. These are thin, biocompatible lenses surgically placed inside the eye, typically between the iris and the natural lens. This intraocular approach provides a safe and reversible solution for corrections far beyond the limits of laser ablation without permanently altering the corneal tissue.

Refractive Lens Exchange (RLE), sometimes called clear lens extraction, is a third option that involves replacing the eye’s natural lens with an artificial intraocular lens. This procedure is similar to cataract surgery and is usually reserved for older patients with extremely high prescriptions or those showing signs of early cataract formation. RLE corrects the refractive error and eliminates the possibility of future cataract development.